img

Global Multiple Myeloma Therapy Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Multiple Myeloma Therapy Market Insights, Forecast to 2034

Multiple myeloma or plasma cell myeloma is a form of cancer of the plasma cells. In this condition, the body produces abnormal plasma cells which collect near the bone marrow and hamper normal functioning of the healthy plasma cells.
Market Analysis and InsightsGlobal Multiple Myeloma Therapy Market
Global Multiple Myeloma Therapy market is expected to reach to US$ 22990 million in 2024, with a positive growth of %, compared with US$ 21620 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Multiple Myeloma Therapy industry is evaluated to reach US$ 33160 million in 2029. The CAGR will be 6.3% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Multiple Myeloma Therapy market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Multiple Myeloma Therapy market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Sanofi
Celgene
Johnson & Johnson
GlaxoSmithKline plc
Roche
AbbVie Inc.
Amgen Inc.
Novartis AG
Millennium Pharmaceuticals
Innate Pharma SA
Segment by Type
Targeted Therapy
Chemotherapy
Radiotherapy
Bone Marrow Transplant
Others

Segment by Application


Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Multiple Myeloma Therapy introduction, etc. Multiple Myeloma Therapy Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Multiple Myeloma Therapy
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple Myeloma Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Targeted Therapy
1.2.3 Chemotherapy
1.2.4 Radiotherapy
1.2.5 Bone Marrow Transplant
1.2.6 Others
1.3 Market by Application
1.3.1 Global Multiple Myeloma Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multiple Myeloma Therapy Market Perspective (2018-2029)
2.2 Global Multiple Myeloma Therapy Growth Trends by Region
2.2.1 Multiple Myeloma Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Multiple Myeloma Therapy Historic Market Size by Region (2018-2024)
2.2.3 Multiple Myeloma Therapy Forecasted Market Size by Region (2024-2029)
2.3 Multiple Myeloma Therapy Market Dynamics
2.3.1 Multiple Myeloma Therapy Industry Trends
2.3.2 Multiple Myeloma Therapy Market Drivers
2.3.3 Multiple Myeloma Therapy Market Challenges
2.3.4 Multiple Myeloma Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Multiple Myeloma Therapy by Players
3.1.1 Global Multiple Myeloma Therapy Revenue by Players (2018-2024)
3.1.2 Global Multiple Myeloma Therapy Revenue Market Share by Players (2018-2024)
3.2 Global Multiple Myeloma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Multiple Myeloma Therapy, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Multiple Myeloma Therapy Market Concentration Ratio
3.4.1 Global Multiple Myeloma Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple Myeloma Therapy Revenue in 2022
3.5 Global Key Players of Multiple Myeloma Therapy Head office and Area Served
3.6 Global Key Players of Multiple Myeloma Therapy, Product and Application
3.7 Global Key Players of Multiple Myeloma Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiple Myeloma Therapy Breakdown Data by Type
4.1 Global Multiple Myeloma Therapy Historic Market Size by Type (2018-2024)
4.2 Global Multiple Myeloma Therapy Forecasted Market Size by Type (2024-2029)
5 Multiple Myeloma Therapy Breakdown Data by Application
5.1 Global Multiple Myeloma Therapy Historic Market Size by Application (2018-2024)
5.2 Global Multiple Myeloma Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Multiple Myeloma Therapy Market Size (2018-2029)
6.2 North America Multiple Myeloma Therapy Market Size by Type
6.2.1 North America Multiple Myeloma Therapy Market Size by Type (2018-2024)
6.2.2 North America Multiple Myeloma Therapy Market Size by Type (2024-2029)
6.2.3 North America Multiple Myeloma Therapy Market Share by Type (2018-2029)
6.3 North America Multiple Myeloma Therapy Market Size by Application
6.3.1 North America Multiple Myeloma Therapy Market Size by Application (2018-2024)
6.3.2 North America Multiple Myeloma Therapy Market Size by Application (2024-2029)
6.3.3 North America Multiple Myeloma Therapy Market Share by Application (2018-2029)
6.4 North America Multiple Myeloma Therapy Market Size by Country
6.4.1 North America Multiple Myeloma Therapy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Multiple Myeloma Therapy Market Size by Country (2018-2024)
6.4.3 North America Multiple Myeloma Therapy Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Multiple Myeloma Therapy Market Size (2018-2029)
7.2 Europe Multiple Myeloma Therapy Market Size by Type
7.2.1 Europe Multiple Myeloma Therapy Market Size by Type (2018-2024)
7.2.2 Europe Multiple Myeloma Therapy Market Size by Type (2024-2029)
7.2.3 Europe Multiple Myeloma Therapy Market Share by Type (2018-2029)
7.3 Europe Multiple Myeloma Therapy Market Size by Application
7.3.1 Europe Multiple Myeloma Therapy Market Size by Application (2018-2024)
7.3.2 Europe Multiple Myeloma Therapy Market Size by Application (2024-2029)
7.3.3 Europe Multiple Myeloma Therapy Market Share by Application (2018-2029)
7.4 Europe Multiple Myeloma Therapy Market Size by Country
7.4.1 Europe Multiple Myeloma Therapy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Multiple Myeloma Therapy Market Size by Country (2018-2024)
7.4.3 Europe Multiple Myeloma Therapy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Multiple Myeloma Therapy Market Size (2018-2029)
8.2 China Multiple Myeloma Therapy Market Size by Type
8.2.1 China Multiple Myeloma Therapy Market Size by Type (2018-2024)
8.2.2 China Multiple Myeloma Therapy Market Size by Type (2024-2029)
8.2.3 China Multiple Myeloma Therapy Market Share by Type (2018-2029)
8.3 China Multiple Myeloma Therapy Market Size by Application
8.3.1 China Multiple Myeloma Therapy Market Size by Application (2018-2024)
8.3.2 China Multiple Myeloma Therapy Market Size by Application (2024-2029)
8.3.3 China Multiple Myeloma Therapy Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Multiple Myeloma Therapy Market Size (2018-2029)
9.2 Asia Multiple Myeloma Therapy Market Size by Type
9.2.1 Asia Multiple Myeloma Therapy Market Size by Type (2018-2024)
9.2.2 Asia Multiple Myeloma Therapy Market Size by Type (2024-2029)
9.2.3 Asia Multiple Myeloma Therapy Market Share by Type (2018-2029)
9.3 Asia Multiple Myeloma Therapy Market Size by Application
9.3.1 Asia Multiple Myeloma Therapy Market Size by Application (2018-2024)
9.3.2 Asia Multiple Myeloma Therapy Market Size by Application (2024-2029)
9.3.3 Asia Multiple Myeloma Therapy Market Share by Application (2018-2029)
9.4 Asia Multiple Myeloma Therapy Market Size by Region
9.4.1 Asia Multiple Myeloma Therapy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Multiple Myeloma Therapy Market Size by Region (2018-2024)
9.4.3 Asia Multiple Myeloma Therapy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Multiple Myeloma Therapy Introduction
11.1.4 Sanofi Revenue in Multiple Myeloma Therapy Business (2018-2024)
11.1.5 Sanofi Recent Developments
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Multiple Myeloma Therapy Introduction
11.2.4 Celgene Revenue in Multiple Myeloma Therapy Business (2018-2024)
11.2.5 Celgene Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Multiple Myeloma Therapy Introduction
11.3.4 Johnson & Johnson Revenue in Multiple Myeloma Therapy Business (2018-2024)
11.3.5 Johnson & Johnson Recent Developments
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Details
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Multiple Myeloma Therapy Introduction
11.4.4 GlaxoSmithKline plc Revenue in Multiple Myeloma Therapy Business (2018-2024)
11.4.5 GlaxoSmithKline plc Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Multiple Myeloma Therapy Introduction
11.5.4 Roche Revenue in Multiple Myeloma Therapy Business (2018-2024)
11.5.5 Roche Recent Developments
11.6 AbbVie Inc.
11.6.1 AbbVie Inc. Company Details
11.6.2 AbbVie Inc. Business Overview
11.6.3 AbbVie Inc. Multiple Myeloma Therapy Introduction
11.6.4 AbbVie Inc. Revenue in Multiple Myeloma Therapy Business (2018-2024)
11.6.5 AbbVie Inc. Recent Developments
11.7 Amgen Inc.
11.7.1 Amgen Inc. Company Details
11.7.2 Amgen Inc. Business Overview
11.7.3 Amgen Inc. Multiple Myeloma Therapy Introduction
11.7.4 Amgen Inc. Revenue in Multiple Myeloma Therapy Business (2018-2024)
11.7.5 Amgen Inc. Recent Developments
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Multiple Myeloma Therapy Introduction
11.8.4 Novartis AG Revenue in Multiple Myeloma Therapy Business (2018-2024)
11.8.5 Novartis AG Recent Developments
11.9 Millennium Pharmaceuticals
11.9.1 Millennium Pharmaceuticals Company Details
11.9.2 Millennium Pharmaceuticals Business Overview
11.9.3 Millennium Pharmaceuticals Multiple Myeloma Therapy Introduction
11.9.4 Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapy Business (2018-2024)
11.9.5 Millennium Pharmaceuticals Recent Developments
11.10 Innate Pharma SA
11.10.1 Innate Pharma SA Company Details
11.10.2 Innate Pharma SA Business Overview
11.10.3 Innate Pharma SA Multiple Myeloma Therapy Introduction
11.10.4 Innate Pharma SA Revenue in Multiple Myeloma Therapy Business (2018-2024)
11.10.5 Innate Pharma SA Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Multiple Myeloma Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Targeted Therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Radiotherapy
Table 5. Key Players of Bone Marrow Transplant
Table 6. Key Players of Others
Table 7. Global Multiple Myeloma Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Multiple Myeloma Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Multiple Myeloma Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 10. Global Multiple Myeloma Therapy Market Share by Region (2018-2024)
Table 11. Global Multiple Myeloma Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Multiple Myeloma Therapy Market Share by Region (2024-2029)
Table 13. Multiple Myeloma Therapy Market Trends
Table 14. Multiple Myeloma Therapy Market Drivers
Table 15. Multiple Myeloma Therapy Market Challenges
Table 16. Multiple Myeloma Therapy Market Restraints
Table 17. Global Multiple Myeloma Therapy Revenue by Players (2018-2024) & (US$ Million)
Table 18. Global Multiple Myeloma Therapy Revenue Share by Players (2018-2024)
Table 19. Global Top Multiple Myeloma Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Therapy as of 2022)
Table 20. Global Multiple Myeloma Therapy Industry Ranking 2021 VS 2022 VS 2024
Table 21. Global 5 Largest Players Market Share by Multiple Myeloma Therapy Revenue (CR5 and HHI) & (2018-2024)
Table 22. Global Key Players of Multiple Myeloma Therapy, Headquarters and Area Served
Table 23. Global Key Players of Multiple Myeloma Therapy, Product and Application
Table 24. Global Key Players of Multiple Myeloma Therapy, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Multiple Myeloma Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 27. Global Multiple Myeloma Therapy Revenue Market Share by Type (2018-2024)
Table 28. Global Multiple Myeloma Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Multiple Myeloma Therapy Revenue Market Share by Type (2024-2029)
Table 30. Global Multiple Myeloma Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 31. Global Multiple Myeloma Therapy Revenue Share by Application (2018-2024)
Table 32. Global Multiple Myeloma Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Multiple Myeloma Therapy Revenue Share by Application (2024-2029)
Table 34. North America Multiple Myeloma Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 35. North America Multiple Myeloma Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Multiple Myeloma Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 37. North America Multiple Myeloma Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Multiple Myeloma Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Multiple Myeloma Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 40. North America Multiple Myeloma Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Multiple Myeloma Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 42. Europe Multiple Myeloma Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Multiple Myeloma Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 44. Europe Multiple Myeloma Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Multiple Myeloma Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Multiple Myeloma Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 47. Europe Multiple Myeloma Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Multiple Myeloma Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 49. China Multiple Myeloma Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Multiple Myeloma Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 51. China Multiple Myeloma Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Multiple Myeloma Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 53. Asia Multiple Myeloma Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Multiple Myeloma Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 55. Asia Multiple Myeloma Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Multiple Myeloma Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Multiple Myeloma Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 58. Asia Multiple Myeloma Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Multiple Myeloma Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 66. Sanofi Company Details
Table 67. Sanofi Business Overview
Table 68. Sanofi Multiple Myeloma Therapy Product
Table 69. Sanofi Revenue in Multiple Myeloma Therapy Business (2018-2024) & (US$ Million)
Table 70. Sanofi Recent Developments
Table 71. Celgene Company Details
Table 72. Celgene Business Overview
Table 73. Celgene Multiple Myeloma Therapy Product
Table 74. Celgene Revenue in Multiple Myeloma Therapy Business (2018-2024) & (US$ Million)
Table 75. Celgene Recent Developments
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Multiple Myeloma Therapy Product
Table 79. Johnson & Johnson Revenue in Multiple Myeloma Therapy Business (2018-2024) & (US$ Million)
Table 80. Johnson & Johnson Recent Developments
Table 81. GlaxoSmithKline plc Company Details
Table 82. GlaxoSmithKline plc Business Overview
Table 83. GlaxoSmithKline plc Multiple Myeloma Therapy Product
Table 84. GlaxoSmithKline plc Revenue in Multiple Myeloma Therapy Business (2018-2024) & (US$ Million)
Table 85. GlaxoSmithKline plc Recent Developments
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche Multiple Myeloma Therapy Product
Table 89. Roche Revenue in Multiple Myeloma Therapy Business (2018-2024) & (US$ Million)
Table 90. Roche Recent Developments
Table 91. AbbVie Inc. Company Details
Table 92. AbbVie Inc. Business Overview
Table 93. AbbVie Inc. Multiple Myeloma Therapy Product
Table 94. AbbVie Inc. Revenue in Multiple Myeloma Therapy Business (2018-2024) & (US$ Million)
Table 95. AbbVie Inc. Recent Developments
Table 96. Amgen Inc. Company Details
Table 97. Amgen Inc. Business Overview
Table 98. Amgen Inc. Multiple Myeloma Therapy Product
Table 99. Amgen Inc. Revenue in Multiple Myeloma Therapy Business (2018-2024) & (US$ Million)
Table 100. Amgen Inc. Recent Developments
Table 101. Novartis AG Company Details
Table 102. Novartis AG Business Overview
Table 103. Novartis AG Multiple Myeloma Therapy Product
Table 104. Novartis AG Revenue in Multiple Myeloma Therapy Business (2018-2024) & (US$ Million)
Table 105. Novartis AG Recent Developments
Table 106. Millennium Pharmaceuticals Company Details
Table 107. Millennium Pharmaceuticals Business Overview
Table 108. Millennium Pharmaceuticals Multiple Myeloma Therapy Product
Table 109. Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapy Business (2018-2024) & (US$ Million)
Table 110. Millennium Pharmaceuticals Recent Developments
Table 111. Innate Pharma SA Company Details
Table 112. Innate Pharma SA Business Overview
Table 113. Innate Pharma SA Multiple Myeloma Therapy Product
Table 114. Innate Pharma SA Revenue in Multiple Myeloma Therapy Business (2018-2024) & (US$ Million)
Table 115. Innate Pharma SA Recent Developments
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple Myeloma Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Multiple Myeloma Therapy Market Share by Type: 2022 VS 2029
Figure 3. Targeted Therapy Features
Figure 4. Chemotherapy Features
Figure 5. Radiotherapy Features
Figure 6. Bone Marrow Transplant Features
Figure 7. Others Features
Figure 8. Global Multiple Myeloma Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Multiple Myeloma Therapy Market Share by Application: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Multiple Myeloma Therapy Report Years Considered
Figure 13. Global Multiple Myeloma Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Multiple Myeloma Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Multiple Myeloma Therapy Market Share by Region: 2022 VS 2029
Figure 16. Global Multiple Myeloma Therapy Market Share by Players in 2022
Figure 17. Global Top Multiple Myeloma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Therapy as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Multiple Myeloma Therapy Revenue in 2022
Figure 19. North America Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Multiple Myeloma Therapy Market Share by Type (2018-2029)
Figure 21. North America Multiple Myeloma Therapy Market Share by Application (2018-2029)
Figure 22. North America Multiple Myeloma Therapy Market Share by Country (2018-2029)
Figure 23. United States Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Multiple Myeloma Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Multiple Myeloma Therapy Market Share by Type (2018-2029)
Figure 27. Europe Multiple Myeloma Therapy Market Share by Application (2018-2029)
Figure 28. Europe Multiple Myeloma Therapy Market Share by Country (2018-2029)
Figure 29. Germany Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Multiple Myeloma Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Multiple Myeloma Therapy Market Share by Type (2018-2029)
Figure 37. China Multiple Myeloma Therapy Market Share by Application (2018-2029)
Figure 38. Asia Multiple Myeloma Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Multiple Myeloma Therapy Market Share by Type (2018-2029)
Figure 40. Asia Multiple Myeloma Therapy Market Share by Application (2018-2029)
Figure 41. Asia Multiple Myeloma Therapy Market Share by Region (2018-2029)
Figure 42. Japan Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Multiple Myeloma Therapy Market Share by Country (2018-2029)
Figure 52. Brazil Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Multiple Myeloma Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Sanofi Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2024)
Figure 59. Celgene Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2024)
Figure 60. Johnson & Johnson Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2024)
Figure 61. GlaxoSmithKline plc Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2024)
Figure 62. Roche Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2024)
Figure 63. AbbVie Inc. Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2024)
Figure 64. Amgen Inc. Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2024)
Figure 65. Novartis AG Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2024)
Figure 66. Millennium Pharmaceuticals Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2024)
Figure 67. Innate Pharma SA Revenue Growth Rate in Multiple Myeloma Therapy Business (2018-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries